Clinical Trials
All Clinical Trials - Page 72 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01508949Phase 2Completed
Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
Liraglutide
- NCT03018886N/ACompleted
Diagnosing Adult Growth Hormone Deficiency
Sermorelin
- NCT00016913Phase 2Completed
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Gonadorelin
- NCT01508923Phase 2Completed
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
Liraglutide
- NCT00021450Phase 3Completed
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Gonadorelin
- NCT01509742Phase 1Completed
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
Liraglutide
- NCT02416271Phase 4Completed
The Forteo Alendronate Comparator Trial
Teriparatide
- NCT01511198Phase 2Completed
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Liraglutide
- NCT01511185Phase 1Completed
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
Liraglutide
- NCT00014586Phase 3Terminated
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00499993Phase 3Completed
Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly
Lanreotide
- NCT00223717Phase 1Completed
Treatment of Supine Hypertension in Autonomic Failure
Desmopressin
- NCT00111215N/ACompleted
Treatment and Management of Women With Bleeding Disorders
Desmopressin
- NCT00223145Phase 3Active Not Recruiting
Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone
Gonadorelin
- NCT00724789N/ACompleted
Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)
Gonadorelin
- NCT00186121Phase 2Completed
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
Gonadorelin
- NCT01509755Phase 2Completed
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00006359Phase 2Completed
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00250796Phase 2Completed
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
Octreotide
- NCT00210457Phase 3Completed
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
Lanreotide
- NCT00006370Phase 2Completed
Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
Octreotide
- NCT00005906Phase 2Completed
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
Octreotide
- NCT00234572Phase 2/Phase 3Completed
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Lanreotide
- NCT00684905Phase 2Completed
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
Gonadorelin
- NCT00729313Phase 3Completed
Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
Lanreotide
- NCT00005044Phase 3Completed
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00130845Phase 3Completed
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Octreotide
- NCT00006269Phase 3Terminated
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Octreotide
- NCT00131144Phase 3Completed
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Octreotide
- NCT00004124Phase 3Completed
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Gonadorelin
- NCT00536653N/ACompleted
Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Gonadorelin
- NCT00386984Phase 3Completed
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
Octreotide
- NCT00004895Phase 2Completed
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Octreotide
- NCT01507311Phase 1Completed
Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
Liraglutide
- NCT00521300Phase 4Completed
Preoperative Octreotide Treatment of Acromegaly
Octreotide
- NCT01507285Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
Liraglutide
- NCT00000400Phase 2Completed
Alendronate and/or Parathyroid Hormone for Osteoporosis
Teriparatide
- NCT00004993Phase 2Completed
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
Teriparatide
- NCT00001860Phase 2Completed
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
Octreotide
- NCT00001849Phase 2Completed
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Octreotide
- NCT01507272Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Male Volunteers
Liraglutide
- NCT00003653Phase 3Completed
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Gonadorelin
- NCT00841113Phase 3Completed
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Sermorelin
- NCT00003734Phase 3Unknown
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00003283Phase 2Completed
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Octreotide
- NCT01188733Phase 1/Phase 2Completed
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
Octreotide
- NCT00002779Phase 2Completed
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
Octreotide
- NCT00006368Phase 1Completed
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Octreotide
- NCT00004438N/ACompleted
Leuprolide in Treating Adults With Hypogonadotropism
Gonadorelin
- NCT00978211Phase 2Completed
DOTA-TOC in Metastasized Neuroendocrine Tumors
Octreotide